Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis
Tài liệu tham khảo
Esper, 2011, Rate and influence of respiratory virus co-infection on pandemic (H1N1) influenza disease, J Infect, 63, 260
Klein, 2016, The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis, Influenza Other Respir Viruses, 10, 394, 10.1111/irv.12398
Rice, 2012, Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States, Crit Care Med, 40, 1487, 10.1097/CCM.0b013e3182416f23
Shah, 2016, Bacterial and viral co-infections complicating severe influenza: incidence and impact among 507 US patients, 2013–14, J Clin Virol, 80, 12, 10.1016/j.jcv.2016.04.008
Martín-Loeches, 2011, Community-acquired respiratory coinfection in critically ill patients with pandemic 2009 influenza A(H1N1) virus, Chest, 139, 555, 10.1378/chest.10-1396
Huttner, 2020, COVID-19: don’t neglect antimicrobial stewardship principles!, Clin Microbiol Infect, 26, 808, 10.1016/j.cmi.2020.04.024
Cox, 2020, Co-infections: potentially lethal and unexplored in COVID-19, Lancet Microbe, 10.1016/S2666-5247(20)30009-4
World Health Organization, 2020
Alhazzani, 2020, Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19), Crit Care Med, 48, e440, 10.1097/CCM.0000000000004363
Garritty
Elliott, 2014, Living systematic reviews: an emerging opportunity to narrow the evidence–practice gap, PLoS Med, 11, 10.1371/journal.pmed.1001603
DerSimonian, 2007, Random-effects model for meta-analysis of clinical trials: an update, Contemp Clin Trials, 28, 105, 10.1016/j.cct.2006.04.004
Deeks, 2019
Hoy, 2012, Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement, J Clin Epidemiol, 65, 934, 10.1016/j.jclinepi.2011.11.014
Arentz, 2020, Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State, JAMA [Internet], 10.1001/jama.2020.4326
Barrasa, 2020, SARS-Cov-2 in Spanish intensive care: early experience with 15-day survival in Vitoria, Anaesth Crit Care Pain Med, 10.1016/j.accpm.2020.04.001
Bhatraju, 2020, Covid-19 in critically ill patients in the Seattle region—case series, N Engl J Med, 10.1056/NEJMoa2004500
Cai Q, Huang D, Ou P, Yu H, Zhu Z, Xia Z et al. COVID-19 in a designated infectious diseases hospital outside Hubei Province, China. Allergy 2020 ((Su, Fu) School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China).
Chen, 2020, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet, 395, 507, 10.1016/S0140-6736(20)30211-7
Chen T, Dai Z, Mo P, Li X, Ma Z, Song S et al. Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China (2019): a single-centered, retrospective study. J Gerontol A Biol Sci Med Sci 2020 (cba, 9502837).
Feng Y, Ling Y, Bai T, Xie Y, Huang J, Li J et al. COVID-19 with different severity: a multi-center study of clinical features. Am J Respir Crit Care Med 2020 (9421642, bzs).
Lian, 2020, Analysis of epidemiological and clinical features in older patients with Corona Virus Disease 2019 (COVID-19) out of Wuhan, Clin Infect Dis, 10.1093/cid/ciaa242
Ling, 2020, Critically ill patients with COVID-19 in Hong Kong: a multicentre retrospective observational cohort study, Crit Care Resusc J Australas Acad Crit Care Med
Liu, 2020, Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease, Chin Med J (Engl)
Liu, 2020, Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury, Sci China Life Sci, 63, 364, 10.1007/s11427-020-1643-8
Mo, 2020, Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China, Clin Infect Dis
Pongpirul, 2020, Clinical characteristics of patients hospitalized with coronavirus disease, Thailand, Emerg Infect Dis, 26, 10.3201/eid2607.200598
Tan, 2020, Epidemiologic and clinical characteristics of 10 children with coronavirus disease 2019 in Changsha, China, J Clin Virol, 127
Wang L, He W, Yu X, Hu D, Bao M, Liu H et al. Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. J Infect 2020 ((Liu, Zhou) Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China).
Wang, 2020, Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China, Clin Infect Dis
Wu, 2020, Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China, JAMA Intern Med [Internet], 10.1001/jamainternmed.2020.0994
Wu, 2020, Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID-19), J Intern Med, 10.1111/joim.13063
Wu, 2020, Clinical characteristics of imported cases of COVID-19 in Jiangsu Province: a multicenter descriptive study, Clin Infect Dis
Xia, 2020, Clinical and CT features in pediatric patients with COVID-19 infection: different points from adults, Pediatr Pulmonol, 10.1002/ppul.24718
Yang, 2020, Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study, Lancet Respir Med [Internet], 10.1016/S2213-2600(20)30079-5
Young, 2020, Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore, JAMA [Internet], 10.1001/jama.2020.3204
Zheng, 2020, Clinical characteristics of children with coronavirus disease 2019 in Hubei, China, Curr Med Sci, 10.1007/s11596-020-2172-6
Zhou, 2020, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet, 395, 1054, 10.1016/S0140-6736(20)30566-3
Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect 2020 (ig9, 7908424).
Rawson, 2020, Bacterial and fungal co-infection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing, Clin Infect Dis, 10.1093/cid/ciaa530
Arabi, 2019, Macrolides in critically ill patients with Middle East Respiratory Syndrome, Int J Infect Dis, 81, 184, 10.1016/j.ijid.2019.01.041
Clancy, 2020, COVID-19, superinfections and antimicrobial development: what can we expect?, Clin Infect Dis
Kumar, 2009, Critically ill patients with 2009 influenza A(H1N1) infection in Canada, JAMA, 302, 1872, 10.1001/jama.2009.1496
2009, Critical care services and 2009 H1N1 influenza in Australia and New Zealand, N Engl J Med, 361, 1925, 10.1056/NEJMoa0908481
MacIntyre, 2018, The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza A(H1N1)pdm09, BMC Infect Dis, 18, 637, 10.1186/s12879-018-3548-0
Memish, 2020, Middle East respiratory syndrome, Lancet, 395, 1063, 10.1016/S0140-6736(19)33221-0
Kozak, 2020, Severity of coronavirus respiratory tract infections in adults admitted to acute care in Toronto, Ontario, J Clin Virol, 126, 104338, 10.1016/j.jcv.2020.104338
Chertow, 2013, Bacterial coinfection in influenza: a grand rounds review, JAMA, 309, 275, 10.1001/jama.2012.194139
2020
Tamma, 2017, Association of adverse events with antibiotic use in hospitalized patients, JAMA Intern Med, 177, 1308, 10.1001/jamainternmed.2017.1938
Buetti, 2020, Early administered antibiotics do not impact mortality in critically ill patients with COVID-19, J Infect
Wu, 2020, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention, JAMA, 323, 1239, 10.1001/jama.2020.2648